Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: Prognostic significance

Annals of Surgical Oncology

Volumn 11, Issue 11, 2004, Pages 983-987

  Gradilone, A ^a   Ribuffo, D ^a   Silvestri, I ^a   Cigna, E ^a   Gazzaniga, P ^a   Nofroni, I ^a   Zamolo, G ^a   Frati, L ^b   Scuderi, N ^a   Agliano A M ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c Dipartimento di Medicina Sperimentale e Patologia   (Italy)

Author keywords

Melanoma; MIA; RT PCR; Sentinel lymph node; Tyrosinase

Indexed keywords

EOSIN; HEMATOXYLIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; MIA PROTEIN, HUMAN; SCLEROPROTEIN; TUMOR PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; GENE EXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; STATISTICAL SIGNIFICANCE; BIOSYNTHESIS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

DISEASE-FREE SURVIVAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 16644391827     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.10.003     Document Type: Article

References (12)

1. Morton DL, Davtyan DG, Wanek LA, Fashag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
2. Retsas S, Henry K, Mohammed MQ, Mac Rae K. Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. Eur J Cancer 2002;38:511-6.
3. Balch CM, Soong S-J, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.
4. Worth AJ, Gallagher RP, Elwood JM, et al. Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Int J Cancer 1989;43:370-5.
5. Wang X, Heller R, Van Voorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;222:768-74.
6. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
7. Matsushita Y, Hatta N, Wakamatsu K, et al. Melanoma inhibitory activity (MIA) as a serum marker for early detection of postsurgical relapse in melanoma patients: comparison with 5-S-cysteinyldopa. Melanoma Res 2002;12:319-23.
8. Bonin S, Niccolini B, Calacione R, et al. Molecular analyses of sentinel lymph nodes: an open question. J Eur Acad Dermatol Venereol 2002;16:34-9.
9. Ribuffo D, Gradilone A, Vonella M, et al. Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ann Surg Oncol 2003;10:396-402.
10. Hochberg M, Lotem M, Gimon Z, Shiloni E, Enk CD. Expression of tyrosinase, MIA and Mart-1 in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol 2002;146:244-9.
11. Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.